Pharmaceutical

UK-based Verdiva launches with $410m and an oral GLP-1RA candidate  

Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.

Jan 10, 2025 - 06:00
UK-based Verdiva launches with $410m and an oral GLP-1RA candidate  
Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.
Read the original article

Tags:

Previous Article

Samsung Biologics and LigaChem extend ADC services deal

Next Article

Palforzia’s peanut allergy treatment use in Europe expanded to toddlers

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: In defense of being ‘Cali sober’

Opinion: In defense of being ‘Cali sober’

May 31, 2023

Promising red-light myopia treatment for children is raising safety concerns among experts

Promising red-light myopia treatment for children is ra...

Feb 3, 2024

Nxera Pharma and Antiverse to design antibodies targeting GPCRs

Nxera Pharma and Antiverse to design antibodies targeti...

Nov 7, 2024